Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway.

Li S, Wang R, Wang T, Zhang W, Xu S, Ren Z, Luo R

Open source

DOI
10.3389/fphar.2026.1865261
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1865261,
  title = {Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway.},
  author = {Li S and Wang R and Wang T and Zhang W and Xu S and Ren Z and Luo R},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1865261},
  url = {https://doi.org/10.3389/fphar.2026.1865261}
}

RIS

TY  - JOUR
TI  - Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway.
AU  - Li S
AU  - Wang R
AU  - Wang T
AU  - Zhang W
AU  - Xu S
AU  - Ren Z
AU  - Luo R
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1865261
UR  - https://doi.org/10.3389/fphar.2026.1865261
ER  - 

APA

S, L., R, W., T, W., W, Z., S, X., Z, R., & R, L. (2026). Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1865261

Source records